Healthcare & Life Sciences
Gene-editing
Gene-editing is a series c plus startup. 1 investor tracked. Status: possibledead.
unknownseries-c-plus
series-c-plus
Stage
1
Investors
About Gene-editing
Gene-editing is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Startup focused on gene-editing technologies.
Explore Gene-editing's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.